FDA Approves Higher Dose Wegovy (semaglutide) for Weight Loss

Fri, 20 Mar 2026 03:17:25 +0000
Pharmaceuticals

The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, known as Wegovy HD, for weight management in certain adults. This approval was granted under the Commissioner's National Priority Voucher pilot program, aiming to expedite treatments for national health priorities.